Vyriad is a clinical-stage company developing proprietary oncolytic virus therapies for the treatment of cancers with significant unmet needs. The potentially life-changing oncolytic viral technologies of Vyriad are the result of decades of research by dedicated researchers and clinicians at Mayo Clinic and the University of Miami. The Company has exclusive licenses to technologies discovered and validated at the Department o...
Vyriad is a clinical-stage company developing proprietary oncolytic virus therapies for the treatment of cancers with significant unmet needs. The potentially life-changing oncolytic viral technologies of Vyriad are the result of decades of research by dedicated researchers and clinicians at Mayo Clinic and the University of Miami. The Company has exclusive licenses to technologies discovered and validated at the Department of Molecular Medicine that Vyriad CEO Dr. Stephen Russell founded at Mayo Clinic, along with its comprehensive oncolytic virotherapy program.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.